Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer

To determine the correlation between tumor pathomorphological response (PMR) after neoadjuvant chemotherapy (NACT) and clinico-morphological and molecular prognostic factors in patients with breast cancer (BC), and to determine the possible impact of the PMR and estrogen receptors (ER), progesterone...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental Oncology
Datum:2009
Hauptverfasser: Timovska, Yu.O., Pivnyuk, V.M., Oliynichenko, G.P., Anikushko, M.F., Zachartseva, L.M., Chekhun, V.F.
Format: Artikel
Sprache:English
Veröffentlicht: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2009
Schlagworte:
Online Zugang:https://nasplib.isofts.kiev.ua/handle/123456789/138139
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Zitieren:Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer / Yu.O. Timovska, V.M. Pivnyuk, G.P. Oliynichenko, M.F. Anikushko, L.M. Zachartseva, V.F. Chekhun // Experimental Oncology. — 2009. — Т. 31, № 4. — С. 231-236. — Бібліогр.: 16 назв. — англ.

Institution

Digital Library of Periodicals of National Academy of Sciences of Ukraine
id nasplib_isofts_kiev_ua-123456789-138139
record_format dspace
spelling Timovska, Yu.O.
Pivnyuk, V.M.
Oliynichenko, G.P.
Anikushko, M.F.
Zachartseva, L.M.
Chekhun, V.F.
2018-06-18T09:43:57Z
2018-06-18T09:43:57Z
2009
Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer / Yu.O. Timovska, V.M. Pivnyuk, G.P. Oliynichenko, M.F. Anikushko, L.M. Zachartseva, V.F. Chekhun // Experimental Oncology. — 2009. — Т. 31, № 4. — С. 231-236. — Бібліогр.: 16 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/138139
To determine the correlation between tumor pathomorphological response (PMR) after neoadjuvant chemotherapy (NACT) and clinico-morphological and molecular prognostic factors in patients with breast cancer (BC), and to determine the possible impact of the PMR and estrogen receptors (ER), progesterone receptors (PR) and Her-2/neu BC status on the disease course. Methods: The data from the medical history of patients on IIB stage (T2N1M0, T3N0M0) (n = 247), who received treatment with NACT, were used. The correlation between the parameters was determined using the Spearman’s coefficient. Patient’s survival was analyzed by Kaplan – Meier method. The association between PMR grades with the risk of disease relapse was estimated by Cox’s regression analysis. Results: PMR grade correlated with tumor differentiation grade (rho = 0.38; p 0.05) and BC subtypes (rho = 0.05; p > 0.05). The patients with the same PMR grades didn’t differ by the number of lymph node metastases (p > 0.05) and differed by the presence of embolus in tumor vessels (p < 0.05). The rates of 3-years disease-free survival (DFS) differed between the groups of patients with different PMR grade (χ2 = 25.5; p < 0.0001). The patients with the grade 2–3 of pR had highest survival (p < 0.05). The groups of patients with identical subtype of BC had different survival rates dependent on PMR grades (for basal subtype (χ2 = 15.176; p < 0.001); luminal A subtype (χ2 = 14.9; p 0.05). The risk of disease relapse depended on PMR grade: for grade 2–3 it was significantly decreased (HR = 0.71, 95% CI — 0.25–2.9, p = 0.0037), and for grade 4–5 it was the highest (HR = –1.23, 95% CI — 0.24–5.05, P = 0.0001), while 0–1 grade had no impact on the risk of disease relapse (HR = 0.22, 95% CI 0.08–0.38; p = 0.7). Conclusion: The data of combined clinical, histological and immunohistochemical analysis have shown that PMR grades may serve as the criteria for individualization of adjuvant treatment of the patients with locally advanced BC.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Original contributions
Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
Article
published earlier
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
collection DSpace DC
title Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
spellingShingle Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
Timovska, Yu.O.
Pivnyuk, V.M.
Oliynichenko, G.P.
Anikushko, M.F.
Zachartseva, L.M.
Chekhun, V.F.
Original contributions
title_short Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
title_full Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
title_fullStr Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
title_full_unstemmed Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
title_sort relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
author Timovska, Yu.O.
Pivnyuk, V.M.
Oliynichenko, G.P.
Anikushko, M.F.
Zachartseva, L.M.
Chekhun, V.F.
author_facet Timovska, Yu.O.
Pivnyuk, V.M.
Oliynichenko, G.P.
Anikushko, M.F.
Zachartseva, L.M.
Chekhun, V.F.
topic Original contributions
topic_facet Original contributions
publishDate 2009
language English
container_title Experimental Oncology
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
format Article
description To determine the correlation between tumor pathomorphological response (PMR) after neoadjuvant chemotherapy (NACT) and clinico-morphological and molecular prognostic factors in patients with breast cancer (BC), and to determine the possible impact of the PMR and estrogen receptors (ER), progesterone receptors (PR) and Her-2/neu BC status on the disease course. Methods: The data from the medical history of patients on IIB stage (T2N1M0, T3N0M0) (n = 247), who received treatment with NACT, were used. The correlation between the parameters was determined using the Spearman’s coefficient. Patient’s survival was analyzed by Kaplan – Meier method. The association between PMR grades with the risk of disease relapse was estimated by Cox’s regression analysis. Results: PMR grade correlated with tumor differentiation grade (rho = 0.38; p 0.05) and BC subtypes (rho = 0.05; p > 0.05). The patients with the same PMR grades didn’t differ by the number of lymph node metastases (p > 0.05) and differed by the presence of embolus in tumor vessels (p < 0.05). The rates of 3-years disease-free survival (DFS) differed between the groups of patients with different PMR grade (χ2 = 25.5; p < 0.0001). The patients with the grade 2–3 of pR had highest survival (p < 0.05). The groups of patients with identical subtype of BC had different survival rates dependent on PMR grades (for basal subtype (χ2 = 15.176; p < 0.001); luminal A subtype (χ2 = 14.9; p 0.05). The risk of disease relapse depended on PMR grade: for grade 2–3 it was significantly decreased (HR = 0.71, 95% CI — 0.25–2.9, p = 0.0037), and for grade 4–5 it was the highest (HR = –1.23, 95% CI — 0.24–5.05, P = 0.0001), while 0–1 grade had no impact on the risk of disease relapse (HR = 0.22, 95% CI 0.08–0.38; p = 0.7). Conclusion: The data of combined clinical, histological and immunohistochemical analysis have shown that PMR grades may serve as the criteria for individualization of adjuvant treatment of the patients with locally advanced BC.
issn 1812-9269
url https://nasplib.isofts.kiev.ua/handle/123456789/138139
citation_txt Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer / Yu.O. Timovska, V.M. Pivnyuk, G.P. Oliynichenko, M.F. Anikushko, L.M. Zachartseva, V.F. Chekhun // Experimental Oncology. — 2009. — Т. 31, № 4. — С. 231-236. — Бібліогр.: 16 назв. — англ.
work_keys_str_mv AT timovskayuo relationbetweenpathomorphologicalresponseintumorsafterneoadjuvantchemotherapyandclinicomorphologicalandmolecularprognosticfactorsinpatientswithbreastcancer
AT pivnyukvm relationbetweenpathomorphologicalresponseintumorsafterneoadjuvantchemotherapyandclinicomorphologicalandmolecularprognosticfactorsinpatientswithbreastcancer
AT oliynichenkogp relationbetweenpathomorphologicalresponseintumorsafterneoadjuvantchemotherapyandclinicomorphologicalandmolecularprognosticfactorsinpatientswithbreastcancer
AT anikushkomf relationbetweenpathomorphologicalresponseintumorsafterneoadjuvantchemotherapyandclinicomorphologicalandmolecularprognosticfactorsinpatientswithbreastcancer
AT zachartsevalm relationbetweenpathomorphologicalresponseintumorsafterneoadjuvantchemotherapyandclinicomorphologicalandmolecularprognosticfactorsinpatientswithbreastcancer
AT chekhunvf relationbetweenpathomorphologicalresponseintumorsafterneoadjuvantchemotherapyandclinicomorphologicalandmolecularprognosticfactorsinpatientswithbreastcancer
first_indexed 2025-12-07T16:58:27Z
last_indexed 2025-12-07T16:58:27Z
_version_ 1850869502515871744